COVID-19 cases (N=350) who presented with respiratory illness symptoms and had a physician-ordered positive SARS-CoV-2 test performed at the Barnes Jewish Hospital between 26 March 2020 and 28 August 2020 (Washington University 350 (WU350) cohort).
Cohort Country: United States of America
Arizona APOE Cohort Study
Cognitively unimpaired 50-90-year-old persons with each common form of APOE genotype providing blood and cerebrospinal fluid samples obtained utilizing the NCRAD protocol with storage and management through NCRAD, amyloid and tau PET and MRI brain imaging data compliant with the SCAN Initiative, and cognitive and behavioral assessment data including the…
Healthy Elderly Active Longevity (HEAL) Cohort “Wellderly”
This study began enrollment at the end of 2007 and included eligible individuals 80 years of age or older, which was later changed to 85 years of age or older. The objective of this study is to obtain blood and/or saliva samples in order to help model health and disease…
Center for Cognitive Neuroscience and Aging (CNSA)
The Center for Cognitive Neuroscience and Aging (CNSA) at the University of Miami is a center focused on the evaluation, management, treatment and care for older persons and their families with memory and other brain disorders affecting cognition. A major focus of this group is early detection of cognitive impairment.…
ASPrin in Reducing Events in the Elderly (ASPREE) & ASPREE-XT
ASPREE is a randomized, double-blind, placebo-controlled clinical trial investigating the effects of 100mg of daily low-dose aspirin in 19,114 healthy older adults, aged ≥70 years (≥65 years for US participants) at enrollment. ASPREE-XT is an ongoing observational follow-up study to examine the long-term effects of aspirin on various health outcomes,…
A4 Study (A4)
The A4 Study was designed as a three-year, placebo-controlled, randomized clinical trial to test whether anti-amyloid treatment can slow the rate of cognitive decline in older individuals from diverse ethnic-racial backgrounds (non-Hispanic White, African American and Latino/Hispanic) with evidence of amyloid accumulation on screening PET scans.
Northern Manhattan Study (NOMAS)
The Northern Manhattan Study (NOMAS) is a research study of stroke and stroke risk factors among the multi-ethnic community of Northern Manhattan, New York. The study is a collaboration between the Department of Neurology at University of Miami and the Neurological Institute at Columbia University. NOMAS is a NINDS-funded study of the population…
Longevity Genes Project (LGP)
The Longevity Genes Project (LGP), established in 1998 at Albert Einstein College of Medicine, recruits Ashkenazi Jewish centenarians (age 95 and older) who are in general good health at age 95, offspring of centenarians, and spouses of offspring in the Eastern United States. The goal of this cross-sectional study is…
LonGenity
The LonGenity study at Albert Einstein College of Medicine has been recruiting community dwelling Ashkenazi Jewish seniors aged 65 or older in the United States since 2008. Offspring of Parents with Exceptional Longevity (OPEL), defined by having at least one parent who lived to age 95 or older and Offspring…
Hillblom Aging Network (HAN)
Participants were enrolled in the Hillblom Aging Network at the University of California, San Francisco (UCSF) Memory and Aging Center. All participants underwent comprehensive neurobehavioral evaluations and met the following inclusionary criteria at baseline: 1) clinically normal based on consensus conference with a neurologist and board-certified neuropsychologist; 2) no history…